As­traZeneca asks fed­er­al judge to de­cide in its fa­vor in drug price ne­go­ti­a­tions law­suit

Law­suits over the In­fla­tion Re­duc­tion Act’s drug price ne­go­ti­a­tions are pick­ing up, with lawyers for As­traZeneca and the gov­ern­ment duk­ing it out in Delaware fed­er­al court in re­cent fil­ings.

On Mon­day, As­traZeneca asked a fed­er­al judge to de­cide in its fa­vor with­out a full tri­al, ar­gu­ing that it “faces con­crete and im­mi­nent in­juries that di­rect­ly re­sult from the un­con­sti­tu­tion­al as­pects of the Drug Price Ne­go­ti­a­tion Pro­gram, and they are re­dress­able by this Court.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.